Holista CollTech (ASX:HCT) Issuance of Debt: A$6.20 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Holista CollTech Issuance of Debt?

Holista CollTech ASX:HCT Issuance of Debt is A$6.20 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Holista CollTech's Issuance of Debt for the six months ended in Dec. 2025 was A$1.34 Mil.

Holista CollTech's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was A$6.20 Mil.

Holista CollTech Issuance of Debt Related Terms

Holista CollTech Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Holista CollTech's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Holista CollTech Issuance of Debt Chart

Holista CollTech Annual Data
Trend Jun16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.14 4.46 6.61 6.20

Holista CollTech Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.47 2.99 3.62 4.86 1.34

Holista CollTech Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$6.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of A$6.20 Mil mean?
Holista CollTech (ASX:HCT) has a Issuance of Debt of A$6.20 Mil as of Dec. 2025. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Holista CollTech and its competitors.
Is Holista CollTech's Issuance of Debt too high?
Holista CollTech's current Issuance of Debt is A$6.20 Mil.
How does Holista CollTech's Issuance of Debt compare to KHC and GIS?
Holista CollTech's Issuance of Debt of A$6.20 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Consumer Packaged Goods company?
A good Issuance of Debt depends on the Consumer Packaged Goods industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Holista CollTech and its competitors. Holista CollTech's current Issuance of Debt is A$6.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Holista CollTech stock overvalued right now?
Based on GuruFocus' analysis, Holista CollTech (ASX:HCT) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.08 — trading 700% above its estimated fair value. The current Issuance of Debt is A$6.20 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Holista CollTech (ASX:HCT), the current Issuance of Debt is A$6.20 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Holista CollTech Business Description

Address 283 Rokeby Road, Subiaco, Perth, WA, AUS, 6008
Holista CollTech Ltd is a research-driven biotech company. Its operating segments include Supplements; Ovine Collagen; Infection Control Solutions; Food Ingredients; and Corporate. The supplements segment is involved in the manufacturing and wholesale distribution of dietary supplements. The ovine collagen segment is involved in the manufacturing and distribution of cosmetic grade collagen. The food ingredients segment is involved in the manufacturing and wholesale distribution of healthy food ingredients. The infection control segment is involved in the infection control solutions. The company generates a majority of its revenue from the Supplements segment. Geographically, it generates a majority of its revenue from Malaysia and the rest from Australia and the United States.